• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁电纳米颗粒实现场控高特异性药物输送,以根除卵巢癌细胞。

Magneto-electric nanoparticles to enable field-controlled high-specificity drug delivery to eradicate ovarian cancer cells.

机构信息

1] Center for Personalized NanoMedicine, Department of Immunology, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida 33199 [2] Electrical and Computer Engineering, College of Engineering, Florida International University, Miami, Florida 33174.

出版信息

Sci Rep. 2013 Oct 16;3:2953. doi: 10.1038/srep02953.

DOI:10.1038/srep02953
PMID:24129652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3797424/
Abstract

The nanotechnology capable of high-specificity targeted delivery of anti-neoplastic drugs would be a significant breakthrough in Cancer in general and Ovarian Cancer in particular. We addressed this challenge through a new physical concept that exploited (i) the difference in the membrane electric properties between the tumor and healthy cells and (ii) the capability of magneto-electric nanoparticles (MENs) to serve as nanosized converters of remote magnetic field energy into the MENs' intrinsic electric field energy. This capability allows to remotely control the membrane electric fields and consequently trigger high-specificity drug uptake through creation of localized nano-electroporation sites. In in-vitro studies on human ovarian carcinoma cell (SKOV-3) and healthy cell (HOMEC) lines, we applied a 30-Oe d.c. field to trigger high-specificity uptake of paclitaxel loaded on 30-nm CoFe₂O₄ @BaTiO₃ MENs. The drug penetrated through the membrane and completely eradicated the tumor within 24 hours without affecting the normal cells.

摘要

纳米技术能够实现高特异性的抗肿瘤药物靶向递送,这将是癌症治疗领域的重大突破,特别是在卵巢癌治疗方面。我们通过一种新的物理概念来应对这一挑战,该概念利用了(i)肿瘤细胞和健康细胞之间的细胞膜电特性差异,以及(ii)磁电纳米颗粒(MENs)将远程磁场能量转换为MENs 固有电场能量的能力。这种能力允许远程控制细胞膜电场,并通过创建局部纳米电穿孔位点来触发高特异性的药物摄取。在对人卵巢癌细胞(SKOV-3)和健康细胞(HOMEC)系的体外研究中,我们施加了 30 奥斯特的直流磁场来触发载紫杉醇的 30nm CoFe₂O₄@BaTiO₃ MENs 的高特异性摄取。药物穿透细胞膜,在 24 小时内完全根除肿瘤,而不影响正常细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba12/3797424/f40dfbc87c87/srep02953-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba12/3797424/2c0e01c52c9a/srep02953-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba12/3797424/949703d2c0ff/srep02953-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba12/3797424/a1d7fffc7d70/srep02953-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba12/3797424/94e6e150ae59/srep02953-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba12/3797424/cb55a01a3769/srep02953-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba12/3797424/f40dfbc87c87/srep02953-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba12/3797424/2c0e01c52c9a/srep02953-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba12/3797424/949703d2c0ff/srep02953-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba12/3797424/a1d7fffc7d70/srep02953-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba12/3797424/94e6e150ae59/srep02953-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba12/3797424/cb55a01a3769/srep02953-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba12/3797424/f40dfbc87c87/srep02953-f6.jpg

相似文献

1
Magneto-electric nanoparticles to enable field-controlled high-specificity drug delivery to eradicate ovarian cancer cells.磁电纳米颗粒实现场控高特异性药物输送,以根除卵巢癌细胞。
Sci Rep. 2013 Oct 16;3:2953. doi: 10.1038/srep02953.
2
Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles.利用磁电纳米颗粒实现靶向和可控的抗癌药物递送与释放。
Sci Rep. 2016 Feb 15;6:20867. doi: 10.1038/srep20867.
3
Magnetoelectric nanoparticles for delivery of antitumor peptides into glioblastoma cells by magnetic fields.磁场介导载抗肿瘤肽磁电纳米粒递送至脑胶质瘤细胞
Nanomedicine (Lond). 2018 Feb;13(4):423-438. doi: 10.2217/nnm-2017-0300. Epub 2018 Jan 18.
4
Carboplatin prodrug conjugated FeO nanoparticles for magnetically targeted drug delivery in ovarian cancer cells.载顺铂前药的 FeO 纳米颗粒用于卵巢癌细胞的磁性靶向药物递送。
J Mater Chem B. 2019 Jan 21;7(3):433-442. doi: 10.1039/c8tb02574f. Epub 2018 Dec 19.
5
Biocompatible APTES-PEG modified magnetite nanoparticles: effective carriers of antineoplastic agents to ovarian cancer.生物相容性APTES-PEG修饰的磁铁矿纳米颗粒:抗肿瘤药物对卵巢癌的有效载体
Appl Biochem Biotechnol. 2014 May;173(1):36-54. doi: 10.1007/s12010-014-0740-6. Epub 2014 Mar 11.
6
Magnetic Fe₃ O ₄ nanoparticles grafted with single-chain antibody (scFv) and docetaxel loaded β-cyclodextrin potential for ovarian cancer dual-targeting therapy.接枝单链抗体(scFv)的磁性Fe₃O₄纳米颗粒及负载多西他赛的β-环糊精用于卵巢癌双靶向治疗的潜力
Mater Sci Eng C Mater Biol Appl. 2014 Sep;42:325-32. doi: 10.1016/j.msec.2014.05.041. Epub 2014 May 24.
7
Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells.多功能纳米医学平台,用于同时向卵巢癌细胞递化疗药物和温和热疗。
Int J Pharm. 2013 Dec 15;458(1):169-80. doi: 10.1016/j.ijpharm.2013.09.032. Epub 2013 Oct 1.
8
The Effect of Millisecond Pulsed Electric Fields (msPEF) on Intracellular Drug Transport with Negatively Charged Large Nanocarriers Made of Solid Lipid Nanoparticles (SLN): In Vitro Study.毫秒级脉冲电场(msPEF)对由固体脂质纳米粒(SLN)制成的带负电荷大纳米载体的细胞内药物转运的影响:体外研究
J Membr Biol. 2016 Oct;249(5):645-661. doi: 10.1007/s00232-016-9906-1. Epub 2016 May 12.
9
"OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo.“OA02”肽有助于紫杉醇载药胶束纳米粒在体内精准靶向卵巢癌。
Cancer Res. 2012 Apr 15;72(8):2100-10. doi: 10.1158/0008-5472.CAN-11-3883. Epub 2012 Mar 6.
10
exploration of the synergistic effect of alternating magnetic field mediated thermo-chemotherapy with doxorubicin loaded dual pH- and thermo-responsive magnetic nanocomposite carriers.探讨交变磁场介导的热化疗与载多柔比星的双 pH 和温敏磁性纳米复合载体的协同作用。
J Mater Chem B. 2020 Dec 8;8(46):10527-10539. doi: 10.1039/d0tb01983f.

引用本文的文献

1
Catalytic Degradation of Organic Dyes Indicates Anti-Proliferative Effects of Magnetoelectric Nanoparticles.有机染料的催化降解表明磁电纳米颗粒具有抗增殖作用。
J Electron Mater. 2025;54(7):5529-5538. doi: 10.1007/s11664-025-11843-5. Epub 2025 Mar 11.
2
Foundational insights for theranostic applications of magnetoelectric nanoparticles.磁电纳米粒子在诊疗应用中的基础见解。
Nanoscale Horiz. 2025 Mar 24;10(4):699-718. doi: 10.1039/d4nh00560k.
3
Multiphysics analysis of the dual role of magnetoelectric nanoparticles in a microvascular environment: from magnetic targeting to electrical activation.

本文引用的文献

1
Externally controlled on-demand release of anti-HIV drug using magneto-electric nanoparticles as carriers.利用磁电纳米粒子作为载体,实现对外控按需释放抗 HIV 药物。
Nat Commun. 2013;4:1707. doi: 10.1038/ncomms2717.
2
Particle shape enhances specificity of antibody-displaying nanoparticles.颗粒形状增强了展示抗体的纳米颗粒的特异性。
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3270-5. doi: 10.1073/pnas.1216893110. Epub 2013 Feb 11.
3
Mitosis-targeted anti-cancer therapies: where they stand.有丝分裂靶向抗癌疗法:现状如何。
磁电纳米粒子在微血管环境中双重作用的多物理场分析:从磁靶向到电激活
Front Bioeng Biotechnol. 2025 Jan 7;12:1467328. doi: 10.3389/fbioe.2024.1467328. eCollection 2024.
4
Theoretical Modeling of the Interactions of CoFeO-BaTiO Magnetoelectric Nanoparticles with Cancer and Healthy Cells.CoFeO-BaTiO磁电纳米颗粒与癌细胞和健康细胞相互作用的理论建模
Curr Med Chem. 2025;32(26):5611-5620. doi: 10.2174/0109298673348662241210111400.
5
Nanotechnology and nanobots unleashed: pioneering a new era in gynecological cancer management - a comprehensive review.纳米技术与纳米机器人的应用:开创妇科癌症管理的新时代——全面综述
Cancer Chemother Pharmacol. 2025 Jan 4;95(1):18. doi: 10.1007/s00280-024-04747-4.
6
Remotely Controlled Surface Charge Modulation of Magnetoelectric Nanogenerators for Swift and Efficient Drug Delivery.用于快速高效药物递送的磁电纳米发电机的远程控制表面电荷调制
ACS Omega. 2024 Jun 15;9(26):28937-28950. doi: 10.1021/acsomega.4c03825. eCollection 2024 Jul 2.
7
Magnetoelectric nanoparticles shape modulates their electrical output.磁电纳米颗粒的形状会调节其电输出。
Front Bioeng Biotechnol. 2023 Aug 25;11:1219777. doi: 10.3389/fbioe.2023.1219777. eCollection 2023.
8
Synthesis and Functional Characterization of CoFeO-BaTiO Magnetoelectric Nanocomposites for Biomedical Applications.用于生物医学应用的CoFeO-BaTiO磁电纳米复合材料的合成与功能表征
Nanomaterials (Basel). 2023 Feb 22;13(5):811. doi: 10.3390/nano13050811.
9
Biocompatible, Multi-Mode, Fluorescent, MRI Contrast Magnetoelectric-Silica Nanoparticles (MagSiNs), for On-Demand Doxorubicin Delivery to Metastatic Cancer Cells.生物相容性、多模式、荧光、磁共振成像造影磁电二氧化硅纳米颗粒(MagSiNs),用于按需将阿霉素递送至转移性癌细胞。
Pharmaceuticals (Basel). 2022 Sep 30;15(10):1216. doi: 10.3390/ph15101216.
10
Magnetoelectric core-shell CoFeO@BaTiO nanorods: their role in drug delivery and effect on multidrug resistance pump activity .磁电核壳结构的CoFeO@BaTiO纳米棒:它们在药物递送中的作用以及对多药耐药泵活性的影响
RSC Adv. 2022 Sep 1;12(38):24958-24979. doi: 10.1039/d2ra03429h. eCollection 2022 Aug 30.
Cell Death Dis. 2012 Oct 18;3(10):e411. doi: 10.1038/cddis.2012.148.
4
Magneto-electric nano-particles for non-invasive brain stimulation.用于非侵入式脑刺激的磁电纳米颗粒。
PLoS One. 2012;7(9):e44040. doi: 10.1371/journal.pone.0044040. Epub 2012 Sep 5.
5
Targeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approach.采用岩藻糖结合纳米颗粒方法靶向胰腺癌癌细胞的抗癌药物递送。
PLoS One. 2012;7(7):e39545. doi: 10.1371/journal.pone.0039545. Epub 2012 Jul 11.
6
Photoswitchable nanoparticles for triggered tissue penetration and drug delivery.光响应纳米颗粒用于触发组织穿透和药物递送。
J Am Chem Soc. 2012 May 30;134(21):8848-55. doi: 10.1021/ja211888a. Epub 2012 Mar 16.
7
Update of randomized trials in first-line treatment.一线治疗中随机试验的更新。
Ann Oncol. 2011 Dec;22 Suppl 8:viii52-viii60. doi: 10.1093/annonc/mdr466.
8
Multiferroic CoFe2O4-Pb(Zr(0.52)Ti(0.48))O3 core-shell nanofibers and their magnetoelectric coupling.多铁性 CoFe2O4-Pb(Zr(0.52)Ti(0.48))O3 核壳纳米纤维及其磁电耦合。
Nanoscale. 2011 Aug;3(8):3152-8. doi: 10.1039/c1nr10288e. Epub 2011 Jun 3.
9
Molecular electroporation and the transduction of oligoarginines.分子电穿孔与多聚精氨酸转导。
Phys Biol. 2009 Dec 11;7:16001. doi: 10.1088/1478-3975/7/1/016001.
10
Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug.使用含有小干扰RNA(siRNA)或细胞毒性药物的靶向微型细胞对耐药肿瘤进行序贯治疗。
Nat Biotechnol. 2009 Jul;27(7):643-51. doi: 10.1038/nbt.1547. Epub 2009 Jun 28.